Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod Study Demonstrated Neflamapimod Improved Cognition, Motor Function and Dementia Progression Relative to Placebo GlobeNewswire December 01, 2021 Melbourne, VIC, Australia; New Haven, CT, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) Neuroscience.